Clinical Trial Results:
A Pilot study to evaluate the Efficacy and Safety of GFT505 (80mg) orally administered once daily for 12 weeks in patients with Type 2 Diabetes mellitus.
A Multicentre, Randomised, Double Blind, Placebo-Controlled study.
Summary
|
|
EudraCT number |
2010-021986-60 |
Trial protocol |
LV |
Global completion date |
03 Jun 2011
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
10 Mar 2016
|
First version publication date |
10 Mar 2016
|
Other versions |
|
Summary report(s) |
Summary of clinical report |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.